Please assess the completion status of the following clinical trial:

Trial Title: A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of mild to moderate essential hypertension (sitting diastolic blood pressure \>= 90 and \< 110 and/or sitting systolic blood pressure \>= 140 and \< 180)~* Diagnosis of obesity (Body Mass Index \>= 27 and \< 50 and steady body weight)~* Female patients must be postmenopausal for at least 1 year, surgically incapable of childbearing, practicing abstinence, or practicing an acceptable method of contraception (requires negative pregnancy test)~Exclusion Criteria:~* Prior exposure or known contraindication or hypersensitivity to topiramate~* Pregnancy, nursing or subjects who plan to become pregnant during the study~* Diagnosis of severe hypertension~* History or diagnosis of Diabetes Mellitus~* A history of diastolic or systolic hypertension secondary to a known cause~* Significant cardiovascular or liver disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).